SCHEMBL13786603

SCHEMBL13786603

CCCCOc1cc(OC)ccc1/C=N/c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.53
▸ HPGD P15428 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ GAA P10253 4/20 0.43
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ CYP1A1 P04798 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP1B1 Q16678 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13786667 0.92 ALDH1A1 (0.48) MAOBGAAMAPTMEN1KMT2A
SCHEMBL14206850 0.88 GAA (0.52) MAOBGAAMAPTMEN1KMT2A
SCHEMBL14221547 0.85 GAA (0.47) MAOBGAAMAPTMEN1KMT2A
SCHEMBL13786439 0.84 MAOB (0.46) MAOBHPGDSMN1; SMN2GAAMAPT
SCHEMBL13785964 0.84 MAOB (0.70) MAOBHPGDSMN1; SMN2MAPTPOLB
SCHEMBL13971352 0.84 ALDH1A1 (0.46) MAOBHPGDGAAMAPTMEN1
SCHEMBL14206353 0.82 GAA (0.46) MAOBHPGDGAAMAPTMEN1
SCHEMBL14204715 0.82 DHODH (0.43) MAOBSMN1; SMN2GAAMAPTMEN1
SCHEMBL14035606 0.79 GAA (0.46) MAOBGAAMAPTMEN1KMT2A
SCHEMBL14205018 0.78 HIF1A (0.38) MAOBSMN1; SMN2GAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186834-A1 DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS MICROBIA, INC. (US) 2009-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186834-A1 DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS NPC1L1, CYP46A1, NPC1 MAOB 1740/4885HPGD 298/4885SMN1; SMN2 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback